Share

    


In This Section

Home / Attend / Other Events

Other Events

 

SITC-1100x534Expanding Access to Cellular and Bispecific Therapies:
Considerations and Recommendations

March 14, 2024 | 4–5 PM CST

For this webinar, ACCC and SITC have gathered feature experts to review the 3 areas of focus: Education, Coordination, and Facilitation in the Expanding Access to Cellular Therapies Report. A live Question & Answer session for attendees interested in beginning their own program will also be offered.
JOIN THE WEBINAR

HCC Education and Protocols to Advance Treatment through Integrated Collaboration

There are numerous challenges for clinicians who manage patients with hepatocellular cancer (HCC). This includes diagnosing and staging patients in a timely manner while staying abreast with the latest clinical advances in the field. The Association of Community Cancer Centers (ACCC)—in partnership with the American Society for Clinical Pathology (ASCP), the Society of Interventional Oncology (SIO) and the France Foundation (TFF), —is committed to ensuring providers are equipped with the knowledge needed to develop practical protocols to inform personalized treatment options for HCC patients.
Learn More

This activity is jointly provided by The France Foundation, Society of Interventional Oncology, American Society for Clinical Pathology, and Association of Community Cancer Centers.

This activity will award AMA PRA Category 1 Credit(s)™ and nursing contact hours.

 

 

Collaboration of Multidisciplines for Biomarker Testing Implementation Needed for Effective Treatment Decisions in mCRC

While the advent of biomarker testing and targeted therapies has significantly transformed outcomes for patients with metastatic colorectal cancer, it can be challenging for multidisciplinary teams to stay abreast of the latest clinical advances in the face of ever-expanding testing and treatment possibilities. The Association of Community Cancer Centers (ACCC)—in partnership with the American Society for Clinical Pathology (ASCP) and the France Foundation—is committed to ensuring providers are equipped with the knowledge needed to apply guidelines and current research on therapeutic targets for mutations in patients with metastatic colorectal cancer as well as engage patients in shared decision-making regarding biomarker testing and treatment options.
Learn More

This activity is jointly provided by The France Foundation, American Society for Clinical Pathology, and Association of Community Cancer Centers.

This activity will award AMA PRA Category 1 Credit(s)™ and nursing contact hours.

For additional CE information, please visit tffevents.com/crc.